Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development

Gad, 2002, 1 Johnson, 1993, Macromolecular transport across nasal and respiratory epithelia, 161 Chien, 1987, Intranasal drug delivery for systemic medications, Crit. Rev. Ther. Drug Carr. Syst., 4, 67 Muranishi, 1993, Rectal and vaginal absorption of peptides and proteins, 199 Neutra, 1993, Transepithelial transport of proteins by intestinal epithelial cells, 107 Harris, 1992, Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci., 81, 1, 10.1002/jps.2600810102 Lee, 1986, Topical ocular drug delivery: recent developments and future challenges, J. Ocul. Pharmacol., 2, 67, 10.1089/jop.1986.2.67 Martinez, 2002, A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals, J. Clin. Pharmacol., 42, 620, 10.1177/00970002042006005 Patel, 2001, Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs, Pharmacogenomics, 2, 401, 10.1517/14622416.2.4.401 Rathbone, 2002, Modified release drug delivery in veterinary medicine, Drug Discov. Today, 7, 823, 10.1016/S1359-6446(02)02362-0 Martinez, 2001, Feasibility of interspecies extrapolation in determining the bioequivalence of animal products intended for intramuscular administration, J. Vet. Pharmacol. Ther., 24, 125, 10.1046/j.1365-2885.2001.00316.x Chang, 1987, Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load, Invest. Ophthalmol. Vis. Sci., 28, 487 Narurkar, 1989, Prodrugs of 5-iodo-2′-deoxyuridine for enhanced ocular transport, Pharm. Res., 6, 887, 10.1023/A:1015968724007 Shih, 1990, Rate limiting barrier to the penetration of ocular hypotensive beta blockers across the corneal epithelium in the pigmented rabbit, J. Ocul. Pharmacol., 6, 329, 10.1089/jop.1990.6.329 Tak, 2001, Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line, J. Pharm. Sci., 90, 1505, 10.1002/jps.1101 Mladenovska, 2002, Biodistribution studies of BSA loaded gelatin microspheres after peroral application, Int. J. Pharm., 242, 251, 10.1016/S0378-5173(02)00168-0 Desai, 1996, Gastrointestinal uptake of biodegradable microparticles: effect of particle size, Pharm. Res., 13, 1838, 10.1023/A:1016085108889 Thomas, 1996, Particle uptake and translocation across epithelial membranes, J. Anat., 189, 487 Hodges, 1995, Uptake and translocation of microparticles in small intestine. Morphology and quantification of particle distribution, Dig. Dis. Sci., 40, 967, 10.1007/BF02064184 Jung, 2000, Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?, Eur. J. Pharm. Biopharm., 50, 147, 10.1016/S0939-6411(00)00084-9 Kotze, 1998, Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), J. Control. Release, 51, 35, 10.1016/S0168-3659(97)00154-5 Dodane, 1999, Effect of chitosan on epithelial permeability and structure, Int. J. Pharm., 182, 21, 10.1016/S0378-5173(99)00030-7 Thanou, 1999, Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea, Int. J. Pharm., 185, 73, 10.1016/S0378-5173(99)00126-X Clausen, 2001, Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs, Eur. J. Pharm. Biopharm., 51, 25, 10.1016/S0939-6411(00)00130-2 Dorkoosh, 2002, Effects of superporous hydrogels on paracellular drug permeability and cytotoxicity studies in Caco-2 cell monolayers, Int. J. Pharm., 241, 35, 10.1016/S0378-5173(02)00115-1 Hamman, 2003, N-Trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells, Drug Dev. Ind. Pharm., 29, 161, 10.1081/DDC-120016724 Kotze, 1997, N-Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2), Pharm. Res., 14, 1197, 10.1023/A:1012106907708 Manganaro, 1997, Review of the transmucosal drug delivery, Mil. Med., 162, 27, 10.1093/milmed/162.1.27 Shao, 1994, Cyclodextrins as mucosal absorption promoters of insulin: II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats, Pharm. Res., 11, 1174, 10.1023/A:1018997101542 Mitra, 2002, Current prodrug strategies via membrane transporters/receptors, Expert Opin. Biol. Ther., 2, 607, 10.1517/14712598.2.6.607 Yang, 2001, Prodrug based optimal drug delivery via membrane transporter/receptor, Expert Opin. Biol. Ther., 1, 159, 10.1517/14712598.1.2.159 1995, 885 Adibi, 1997, The oligopeptide transporter (Pept-1) in human intestine: biology and function, Gastroenterology, 113, 332, 10.1016/S0016-5085(97)70112-4 Fei, 1994, Expression cloning of a mammalian proton-coupled oligopeptide transporter, Nature, 368, 563, 10.1038/368563a0 Liang, 1995, Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization, J. Biol. Chem., 270, 6456, 10.1074/jbc.270.12.6456 Bolger, 1998, Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1, J. Pharm. Sci., 87, 1286, 10.1021/js980090u Friedrichsen, 2001, Model prodrugs designed for the intestinal peptide transporter. A synthetic approach for coupling of hydroxy-containing compounds to dipeptides, Eur. J. Pharm. Sci., 14, 13, 10.1016/S0928-0987(01)00137-3 Neumann, 2003, Delta-aminolevulinic acid transport in cancer cells of the human extrahepatic biliary duct, J. Pharmacol. Exp. Ther., 305, 219, 10.1124/jpet.102.046573 Naruhashi, 2002, PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine, Pharm. Res., 19, 1417, 10.1023/A:1020436028194 Ramamoorthy, 1995, Proton/peptide cotransporter (PEPT 2) from human kidney: functional characterization and chromosomal localization, Biochim. Biophys. Acta, 1240, 1, 10.1016/0005-2736(95)00178-7 Liu, 1995, Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney, Biochim. Biophys. Acta, 1235, 461, 10.1016/0005-2736(95)80036-F Herrera-Ruiz, 2003, Current perspectives on established and putative mammalian oligopeptide transporters, J. Pharm. Sci., 92, 691, 10.1002/jps.10303 Sakata, 2001, Cloning of a lymphatic peptide/histidine transporter, Biochem. J., 356, 53, 10.1042/0264-6021:3560053 Kottra, 2002, PEPT1 as a paradigm for membrane carriers that mediate electrogenic bidirectional transport of anionic, cationic, and neutral substrates, J. Biol. Chem., 277, 32683, 10.1074/jbc.M204192200 Shen, 2003, Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus, J. Biol. Chem., 278, 4786, 10.1074/jbc.M207397200 Anand, 2002, Mechanism of corneal permeation of l-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea, Pharm. Res., 19, 1194, 10.1023/A:1019806411610 Christensen, 1990, Role of amino acid transport and countertransport in nutrition and metabolism, Physiol. Rev., 70, 43, 10.1152/physrev.1990.70.1.43 Tamai, 2000, Transporter-mediated permeation of drugs across the blood–brain barrier, J. Pharm. Sci., 89, 1371, 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D Bridges, 1999, A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system, Curr. Pharm. Des., 5, 363, 10.2174/138161280505230110101259 Esslinger, 1998, Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate, Bioorg. Med. Chem. Lett., 8, 3101, 10.1016/S0960-894X(98)00560-5 Cooper, 1998, Structural selectivity and molecular nature of l-glutamate transport in cultured human fibroblasts, Arch. Biochem. Biophys., 353, 356, 10.1006/abbi.1998.0626 Klockner, 1994, Functional properties and substrate specificity of the cloned l-glutamate/l-aspartate transporter GLAST-1 from rat brain expressed in Xenopus oocytes, J. Neurosci., 14, 5759, 10.1523/JNEUROSCI.14-10-05759.1994 Uchino, 2002, Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition, Mol. Pharmacol., 61, 729, 10.1124/mol.61.4.729 Wheeler, 2002, Gabapentin. Pfizer, Curr. Opin. Investig. Drugs, 3, 470 Balakrishnan, 2002, Carrier mediated uptake of l-tyrosine and its competitive inhibition by model tyrosine linked compounds in a rabbit corneal cell line (SIRC)-strategy for the design of transporter/receptor targeted prodrugs, Int. J. Pharm., 247, 115, 10.1016/S0378-5173(02)00405-2 Yang, 2001, Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir, J. Pharm. Sci., 90, 617, 10.1002/1520-6017(200105)90:5<617::AID-JPS1018>3.0.CO;2-5 Yang, 2001, Nasal absorption of tyrosine-linked model compounds, J. Pharm. Sci., 90, 340, 10.1002/1520-6017(200103)90:3<340::AID-JPS9>3.0.CO;2-F Griffith, 1996, Nucleoside and nucleobase transport systems of mammalian cells, Biochim. Biophys. Acta, 1286, 153, 10.1016/S0304-4157(96)00008-1 Kraupp, 1995, Nucleobase and nucleoside transport in mammalian cells, Wien. Klin. Wochenschr., 107, 677 de Koning, 2000, Nucleobase transporters (review), Mol. Membr. Biol., 17, 75, 10.1080/09687680050117101 Cass, 1999, Nucleoside transporters of mammalian cells, Pharm. Biotechnol., 12, 313, 10.1007/0-306-46812-3_12 Kiss, 2000, Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain, Biochem. J., 352, 363, 10.1042/0264-6021:3520363 Schaner, 1999, Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system, J. Pharmacol. Exp. Ther., 289, 1487 Balimane, 1999, Involvement of multiple transporters in the oral absorption of nucleoside analogues, Adv. Drug Deliv. Rev., 39, 183, 10.1016/S0169-409X(99)00026-5 Vickers, 2002, Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae, Biochem. Cell. Biol., 80, 639, 10.1139/o02-148 Gutierrez, 1993, Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney, Biochim. Biophys. Acta, 1149, 202, 10.1016/0005-2736(93)90202-B Leung, 2001, Characterization of nucleoside transport systems in cultured rat epididymal epithelium, Am. J. Physiol., Cell Physiol., 280, C1076, 10.1152/ajpcell.2001.280.5.C1076 Schaner, 1999, Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus, Adv. Drug Deliv. Rev., 39, 51, 10.1016/S0169-409X(99)00019-8 Borgland, 1997, Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells, J. Pharmacol. Exp. Ther., 281, 347 Washington, 1995, Mechanisms of nucleobase transport in rabbit choroid plexus. Evidence for a Na(+)-dependent nucleobase transporter with broad substrate selectivity, J. Biol. Chem., 270, 22816, 10.1074/jbc.270.39.22816 Kraupp, 1995, Membrane transport of nucleobases: interaction with inhibitors, Gen. Pharmacol., 26, 1185, 10.1016/0306-3623(95)00005-L Suzuki, 1999, 387 Booker, 2001, S-8921 (Shionogi), Curr. Opin. Investig. Drugs, 2, 393 Izzat, 2000, New molecular targets for cholesterol-lowering therapy, J. Pharmacol. Exp. Ther., 293, 315 Kullak-Ublick, 1997, Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas, Gastroenterology, 113, 1295, 10.1053/gast.1997.v113.pm9322525 Halestrap, 1999, The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation, Biochem. J., 343, 281, 10.1042/0264-6021:3430281 Bonen, 2001, The expression of lactate transporters (MCT1 and MCT4) in heart and muscle, Eur. J. Appl. Physiol., 86, 6, 10.1007/s004210100516 Lin, 1998, Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter, J. Biol. Chem., 273, 28959, 10.1074/jbc.273.44.28959 Hosoya, 2001, MCT1-mediated transport of l-lactic acid at the inner blood–retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina, Pharm. Res., 18, 1669, 10.1023/A:1013310210710 Li, 1999, Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells, J. Pharmacol. Exp. Ther., 290, 958 Li, 1999, Role of the monocarboxylic acid transport system in the intestinal absorption of an orally active beta-lactam prodrug: carindacillin as a model, Int. J. Pharm., 191, 151, 10.1016/S0378-5173(99)00299-9 Tsuji, 1993, Intestinal brush-border transport of the oral cephalosporin antibiotic, cefdinir, mediated by dipeptide and monocarboxylic acid transport systems in rabbits, J. Pharm. Pharmacol., 45, 996, 10.1111/j.2042-7158.1993.tb05645.x Cunha-Vaz, 1997, The blood–ocular barriers: past, present, and future, Doc. Ophthalmol., 93, 149, 10.1007/BF02569055 Cunha-Vaz, 1979, The blood–ocular barriers, Surv. Ophthalmol., 23, 279, 10.1016/0039-6257(79)90158-9 Cunha-Vaz, 1976, The blood–retinal barriers, Doc. Ophthalmol., 41, 287, 10.1007/BF00146764 Philp, 1998, Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE, Am. J. Physiol., 274, R1824 Philp, 2001, Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia, Am. J. Physiol., Cell Physiol., 280, C1319, 10.1152/ajpcell.2001.280.5.C1319 Giasson, 1994, Facilitated transport of lactate by rabbit corneal endothelium, Exp. Eye Res., 59, 73, 10.1006/exer.1994.1082 Bonanno, 1990, Lactate-proton cotransport in rabbit corneal epithelium, Curr. Eye Res., 9, 707, 10.3109/02713689008999587 Chen, 1990, Lactate transport and glycolytic activity in the freshly isolated rabbit cornea, Arch. Biochem. Biophys., 276, 70, 10.1016/0003-9861(90)90011-M Manfredini, 2002, Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity, J. Med. Chem., 45, 559, 10.1021/jm015556r Bridges, 2002, Transcellular transfer of folate across the retinal pigment epithelium, Curr. Eye Res., 24, 129, 10.1076/ceyr.24.2.129.8167 Chancy, 2000, Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium, J. Biol. Chem., 275, 20676, 10.1074/jbc.M002328200 Smith, 1999, Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina, Invest. Ophthalmol. Vis. Sci., 40, 840 Ishizawa, 1992, Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans, J. Pharmacobio-dyn., 15, 481, 10.1248/bpb1978.15.481 Tsuji, 1989, Na+ and pH dependent transport of foscarnet via the phosphate carrier system across intestinal brush-border membrane, Biochem. Pharmacol., 38, 1019, 10.1016/0006-2952(89)90296-7 Kayano, 1990, Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6), J. Biol. Chem., 265, 13276, 10.1016/S0021-9258(19)38295-X Miyamoto, 1994, Characterization of the rabbit intestinal fructose transporter (GLUT5), Biochem. J., 303, 877, 10.1042/bj3030877 Hediger, 1987, Expression cloning and cDNA sequencing of the Na+/glucose co-transporter, Nature, 330, 379, 10.1038/330379a0 Hediger, 1995, Mammalian ion-coupled solute transporters, J. Physiol., 482, 7S, 10.1113/jphysiol.1995.sp020559 Haga, 1990, Hypoglycemic effect of intestinally administered monosaccharide-modified insulin derivatives in rats, Chem. Pharm. Bull. (Tokyo), 38, 1983, 10.1248/cpb.38.1983 Mizuma, 1992, Intestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs, Biochem. Pharmacol., 43, 2037, 10.1016/0006-2952(92)90649-4 Mizuma, 1993, Comparative study of active absorption by the intestine and disposition of anomers of sugar-conjugated compounds, Biochem. Pharmacol., 45, 1520, 10.1016/0006-2952(93)90053-Y Lu, 2002, Folate-mediated delivery of macromolecular anticancer therapeutic agents, Adv. Drug Deliv. Rev., 54, 675, 10.1016/S0169-409X(02)00042-X Ward, 2000, Folate-targeted non-viral DNA vectors for cancer gene therapy, Curr. Opin. Mol. Ther., 2, 182 Ni, 2002, Folate receptor targeted delivery of liposomal daunorubicin into tumor cells, Anticancer Res., 22, 2131 Pan, 2002, Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes, Anticancer Res., 22, 1629 Kursa, 2003, Novel shielded transferrin–polyethylene glycol–polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer, Bioconjug. Chem., 14, 222, 10.1021/bc0256087 Tan, 2003, Antibody targeted gene transfer to endothelium, J. Gene Med., 5, 311, 10.1002/jgm.358 Xu, 2002, Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes, Mol. Cancer Ther., 1, 337 Qian, 2002, Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway, Pharmacol. Rev., 54, 561, 10.1124/pr.54.4.561 Gijsens, 2002, Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes, Int. J. Cancer, 101, 78, 10.1002/ijc.10548 Kovar, 2002, In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13, J. Drug Target., 10, 23, 10.1080/10611860290007496 Xu, 2001, Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv, Mol. Med., 7, 723, 10.1007/BF03401962 Yang, 2001, Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene, Anticancer Res., 21, 1777 Bijsterbosch, 2001, Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl) adenine against hepatitis B virus, Mol. Pharmacol., 60, 521 Russell-Jones, 1995, Vitamin B12 mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin, Bioconjug. Chem., 6, 459, 10.1021/bc00034a016 Russell-Jones, 1995, Synthesis of LHRH antagonists suitable for oral administration via the vitamin B12 uptake system, Bioconjug. Chem., 6, 34, 10.1021/bc00031a600